WAM
TTPH

Weiss Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Weiss Asset Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-886
Closed -$54K – 293
2018
Q1 		$54K Buy
886
+370
+72% +$32.5K ﹤0.01% 220
2017
Q4 		$65K Buy
+516
New +$66.1K 0.01% 242

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Weiss Asset Management's TTPH Position: Q2 2018 in Review

Weiss Asset Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2018, closing a stake of 886 shares — an estimated $54K sold.

Weiss Asset Management first reported a position in TTPH in Q4 2017 and held it in 2 quarters. The position peaked at $65K in Q4 2017. 90 funds tracked by Wall St. Rank hold TTPH as of Q2 2018.

  • Weiss Asset Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Weiss Asset Management sold 886 Tetraphase Pharmaceuticals, Inc. shares in Q2 2018, an estimated $54K.
  • Weiss Asset Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
  • Weiss Asset Management's Tetraphase Pharmaceuticals, Inc. position peaked at $65K in Q4 2017.
  • 90 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2018.

Based on Weiss Asset Management's 13F filing for Q2 2018, filed 13 Aug 2018.